Compare Mast Therapeutics vs OncoGenex Pharmaceuticals
Customers evaluate the quality of Mast Therapeutics's products using the following success metrics.
Overview
Mast Therapeutics is 29 yrs old and is based in United States.
Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. Mast's lead product candidate, AIR001, is a sodium nitrite solution for intermittent inhalation via nebulization in Phase 2 clinical development for the treatment of HFpEF.
OncoGenex Pharmaceuticals is based in United States
OncoGenex Pharmaceuticals (NASDAQ: OGXI) is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients.
Demo Video
Leadership
Carrie McQueen (Chief Financial Officer)
Steve Anderson (Chief Financial Officer)
Funding
Investors
Savara, Centrum Bank AG
Qwest Communications, Milestone Medica
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Mast Therapeutics has not claimed their profile.
Work for Mast Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Mast Therapeutics?
Claim your profile now.
Information not available because OncoGenex Pharmaceuticals has not claimed their profile.
Work for OncoGenex Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for OncoGenex Pharmaceuticals?
Claim your profile now.